Just a sample of the Echomail archive
Cooperative anarchy at its finest, still active today. Darkrealms is the Zone 1 Hub.
|    EARTH    |    Uhh, that 3rd rock from the sun?    |    8,931 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 6,002 of 8,931    |
|    ScienceDaily to All    |
|    Benefits of exercise may vary greatly in    |
|    04 May 22 22:30:48    |
      MSGID: 1:317/3 627352fa       PID: hpt/lnx 1.9.0-cur 2019-01-08       TID: hpt/lnx 1.9.0-cur 2019-01-08        Benefits of exercise may vary greatly in primary mitochondrial disease        While the benefits of exercise may outweigh the risks, genetic status       should be considered when recommending it as therapy                Date:        May 4, 2022        Source:        Children's Hospital of Philadelphia        Summary:        Researchers demonstrated that the benefits of endurance exercise        can vary based on the type of mutation involved in mitochondrial        disease, and while the benefits of exercise tend to outweigh the        risks, the mitochondrial genetic status of patients should be        taken into consideration when recommending exercise as therapy.                            FULL STORY       ==========================================================================       Mitochondria serve as the main source of energy production in our cells,       and endurance exercise is generally known to improve the function of       mitochondria.              However, the benefits of exercise in patients with primary mitochondrial       diseases, which are heterogeneous and caused by a variety of genetic       mutations, were largely unknown.                     ==========================================================================       In a new study, researchers at Children's Hospital of Philadelphia (CHOP)       demonstrated that the benefits of endurance exercise can vary based       on the type of mutation involved in mitochondrial disease, and while       the benefits of exercise outweigh the risks, the mitochondrial genetic       status of patients should be taken into consideration when recommending       exercise as therapy. The findings were published online today by the       Proceedings of the National Academy of Sciences.              Primary mitochondrial diseases represent the most prevalent inherited       metabolic disorders, affecting approximately 1 in every 4,200       people. These disorders can be caused by hundreds of different mutations       in the nuclear DNA (DNA within our cells) or mitochondrial DNA (mtDNA, or       the DNA within the mitochondria within our cells). Universal treatments       for these patients are limited. However, endurance exercise has been       shown to improve mitochondrial function in healthy people and reduce       the risk of developing secondary metabolic disorders like diabetes or       neurodegenerative diorders.              However, these recommendations were based on healthy people without       primary mitochondrial disease. Therefore, researchers wanted to determine       effectiveness for these patients and whether they are actually benefitting       from endurance exercise.              "There was not a concensus among clinicians who see patients with       mitochondrial disease whether endurance exercise truly offers benefits,"       said Patrick Schaefer, PhD, a postdoctoral fellow at the Center for       Mitochondrial and Epigenomic Medicine at CHOP and first author of the       study. "Exercise helps create more mitochondria, but if those mitochondria       still have the mutations associated with primary mitochondrial disease,       there is a chance that exercise may put some patients at risk." Because       of the heterogeneity of primary mitochondrial disease among patients, the       researchers used animal models to study five mutations responsible for the       disease. The goal of the study was to determine the relationship between       mitochondrial mutations, endurance exercise response, and the underlying       molecular pathways in these models with distinct mitochondrial mutations.              The study found that endurance exercise had different impacts on the       models depending on the mutation involved. Exercise improved response       in the model with the mtDNA ND6 mutation in complex I. The model with       a CO1 mutation affecting complex IV showed significantly fewer positive       effects related to exercise, and the model with a ND5 complex 1 mutation       did not respond to exercise at all. In the model that was deficient in       nuclear DNA Ant1, endurance exercise actually worsened cardiomyopathy.              Additionally, the researchers were able to correlate the gene expression       profile of skeletal muscle and heart in the model with exercise response       and identified oxidative phosphorylation, amino acid metabolism, and       cell cycle regulation as key pathways in exercise response, suggesting       how the model might be adapted to study exercise responses in humans       with primary mitochondrial disease.              Despite mixed responses of the models used in this study, the authors note       that the benefits of exercise outweigh the risks in most cases. However,       the physical and mitochondrial status of the patient should be taken into       account when recommending therapeutic exercises. Additionally, the study       could help researchers identify biomarkers and pathways to help predict       the mitochondrial response to exercise both in mitochondrial patients       and the healthy population harboring different mitochondrial haplogroups.              "This work is of fundamental importance in demonstrating that individuals       with different mitochondrial bioenergetics will respond differently       to endurance exercise," said senior study author Douglas C. Wallace,       PhD, director of the Center for Mitochondrial and Epigenomic Medicine       at CHOP and the Michael and Charles Barnett Endowed Chair in Pediatric       Mitochondrial Medicine and Metabolic Diseases. "This is of broad relevance       to individuals ranging from athletes to patients with mitochondrial       disease, and everyone in between." This study was supported by the German       Research Foundation through grant SCHA 2182/1-1, the National Institutes       of Health grants NS021328, MH108592, and OD010944, and U.S. Department       of Defense grants W81XWH16-1-0401 and W81XWH-21- 1-0128. Schematics were       created with BioRender.com.                     ==========================================================================       Story Source: Materials provided by       Children's_Hospital_of_Philadelphia. Note: Content may be edited for       style and length.                     ==========================================================================       Journal Reference:        1. Patrick M. Schaefer, Komal Rathi, Arrienne Butic, Wendy Tan,        Katherine        Mitchell, Douglas C. Wallace. Mitochondrial mutations alter        endurance exercise response and determinants in mice. Proceedings        of the National Academy of Sciences, 2022; 119 (18) DOI:        10.1073/pnas.2200549119       ==========================================================================              Link to news story:       https://www.sciencedaily.com/releases/2022/05/220504110430.htm              --- up 9 weeks, 2 days, 10 hours, 51 minutes        * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)       SEEN-BY: 15/0 106/201 114/705 123/120 129/330 331 153/7715 218/700       SEEN-BY: 229/110 111 317 400 426 428 470 664 700 292/854 298/25 305/3       SEEN-BY: 317/3 320/219 396/45       PATH: 317/3 229/426           |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca